Celldex Announces Upcoming Oral Presentation on CDX-301 at the American ... GlobeNewswire (press release) The Company previously announced that it plans to initiate a pilot study in hematopoietic stem cell transplant by year end 2013. CDX-301 or Flt3L is a potent cytokine that stimulates the expansion and differentiation of hematopoietic progenitor and ... |
